Stellate Ganglion Block in the Treatment of Posttraumatic Stress Disorder
A legfontosabb adatok
- Ki végzi
- The Royal's Institute of Mental Health Research
- Hol
- Kanada1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Csak meghívásos
- Fázis
- 3. fázis
- Résztvevők
- 54 fő, tervezett
- Kezdés
- 2024. márc. 30.
- Várható befejezés
- 2027. jan. 30.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoport
- A vizsgált kezelések
- 5 mL of 0.5% preservative-free bupivacaine
- A regiszteradat frissítve
- 2025. július 25.
Ki vehet részt
- Életkor
- 18 év – 69 év
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 27 feltétel megnézéseKevesebb
Ki vehet részt
- Diagnosis of PTSD according to DSM-5 criteria with prominent and persistent cluster E hyperarousal symptoms
- Age 18-69 years
- Under care of a mental health clinician
- Not benefited from adequate trials of pharmacological or psychological evidence-based treatment and/or a preference and consent for a trial of SGB
Ki nem vehet részt
- Diagnosis of bipolar or psychotic disorder
- History of bleeding disorder (based on chart and verbal report from patient)
- Infection, mass or anatomic abnormalities at target injection site
- Myocardial infarction within 6 months of procedure (based on chart and verbal report from patient)
- Pathologic bradycardia or irregularities of heart rate or rhythm (based on chart and verbal report from patient)
- History of glaucoma (based on chart and verbal report from patient)
- Uncontrolled seizure disorder (based on chart and verbal report from patient)
- Known history of allergy to local anesthetics (based on chart and verbal report from patient)
- Active systemic infection (based on chart and verbal report from patient)
- Any other condition that in the opinion of the investigator could create a hazard to the participant's safety, endanger the study procedures, or interfere with the interpretation of study results
- Assessed with high risk for suicide in the last 30 days (per patient's treating clinician at OSI clinic)
- Moderate to severe substance use within the last 30 days (based on chart and verbal report from patient)
- In process of disability assessment or legal action
- Moderate or severe TBI (based on chart and verbal report from patient)
- Pregnancy or breastfeeding
- Current anticoagulant use (eligible if can be held before the procedure)
- Symptomatic hypotension (BP<90/60 + clinical symptoms of hypotension)
- Phrenic or laryngeal nerve palsy (based on chart and verbal report from patient)
- Severe COPD (based on chart and verbal report from patient)
- Pneumothorax (based on chart and verbal report from patient)
- Contralateral pneumonectomy or non-functional lung (based on chart and verbal report from patient)
- Patient refusal/inability to tolerate procedure/positioning
- Contraindication to MR imaging
A fő feltételek kérdésként
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 18 és 69 év között vagy?
Hol van ez a vizsgálat?
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
The most common treatment for Posttraumatic Stress Disorder (PTSD) is trauma-focused therapy and/or prescription of medication(s). However, these treatments may not directly reduce symptoms associated with PTSD, making it difficult for patients to be treated for this condition and recover. Stellate ganglion block (SGB) is a medical procedure that involves injection of a local anesthetic (a medication that causes reduced sensation/feeling in a given area) around the stellate ganglion, which is a collection of nerves near the base of the neck. This procedure causes a short-lived, temporary shutdown of nerve signals (up to 5-7 hours) and is commonly performed in Canada for certain pain and medical conditions. In the last decade, several studies, including those involving members of military groups, have shown that SGB can result in a rapid and sustained drop in symptoms related to PTSD such as overwhelming anxiety, increased irritability, heightened alertness, and exaggerated startle. Considering these results and the known safety of this procedure (as demonstrated by previous research and use in other illnesses), SGB has been increasingly used to treat PTSD among veterans in the United States but has not yet been evaluated in Canada. More research is thereby needed to use SBG as a method of PTSD treatment in Canada, and to better understand how it works to reduce symptoms associated with this condition. Health Canada, the organization which oversees clinical trials such as this one, has not approved the use of the SGB procedure for PTSD in the general population, however Health Canada has allowed the use of SGB in this study to better understand how it works and how it may be used in the future to treat PTSD-related symptoms in those who feel that common treatments are not effective.
A vizsgálat 2 csoportja
- Single SGBEgyéb csoport
This arm will receive a single 5 mL dose of 0.5% preservative-free bupivacaine.
Kezelés: 5 mL of 0.5% preservative-free bupivacaine
- Repeated SGBEgyéb csoport
This arm will receive two 5 mL doses of 0.5% preservative-free bupivacaine.
Kezelés: 5 mL of 0.5% preservative-free bupivacaine
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Stellate Ganglion Block in the Treatment of Posttraumatic Stress Disorder: Outcome Evaluation, Mechanism of Action, and Integration in Care - A Phase III Randomized Controlled Trial
- Kérdések a feltételekről
- Forrás: NCT05427500: ki vehet részt
- A regiszteradat frissítve
- 2025. július 25.